ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global JAK and PI3K Signaling Pathway Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-18I9810
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global JAK and PI3K Signaling Pathway Market Insights Forecast to 2028
BUY CHAPTERS

Global JAK and PI3K Signaling Pathway Market Insights, Forecast to 2030

Code: QYRE-Auto-18I9810
Report
December 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer HealthCare Pharmaceuticals
AbbVie
Astrazeneca plc
Curis
Daiichi Sankyo
Exelixis Inc
Genentech Inc
Infinity Pharmaceuticals
Merck
Rigel Pharmaceuticals
TG Therapeutics
Sanofi Oncology
Vertex Pharmaceuticals
Wilex

JAK and PI3K Signaling Pathway Market

Therapies related to the JAK and PI3K signaling pathways have the potential to target diseases such as cancer and inflammatory diseases, and no suitable drugs are currently available. Current therapies can reduce the burden of disease, but they cannot be cured.
Market Analysis and Insights: Global JAK and PI3K Signaling Pathway Market
The global JAK and PI3K Signaling Pathway market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Significant progress has been made in understanding the complexity of signaling pathways such as JAK and PI3K over the past few years. At the same time, great progress has been made in the isolation of target-specific therapies / inhibitors targeting abnormal signals in these pathways. After approval of ruxolitinib (for bone marrow fibrosis) and tofacitinib (for rheumatoid arthritis), the treatment of JAK and PI3K cell signaling pathways has focused on cancer lines and inflammatory diseases.
Report Covers:
This report presents an overview of global market for JAK and PI3K Signaling Pathway market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of JAK and PI3K Signaling Pathway, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for JAK and PI3K Signaling Pathway, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the JAK and PI3K Signaling Pathway revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global JAK and PI3K Signaling Pathway market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for JAK and PI3K Signaling Pathway revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of JAK and PI3K Signaling Pathway Market Report

Report Metric Details
Report Name JAK and PI3K Signaling Pathway Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer HealthCare Pharmaceuticals, AbbVie, AstraZeneca, Curis, Daiichi Sankyo, Exelixis, Genentech, Infinity Pharmaceuticals, Merck & Co., Rigel Pharmaceuticals, TG Therapeutics, Sanofi Oncology, Vertex Pharmaceuticals, WILEX AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of JAK and PI3K Signaling Pathway in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of JAK and PI3K Signaling Pathway companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, JAK and PI3K Signaling Pathway revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the JAK and PI3K Signaling Pathway Market report?

Ans: The main players in the JAK and PI3K Signaling Pathway Market are Bayer HealthCare Pharmaceuticals, AbbVie, AstraZeneca, Curis, Daiichi Sankyo, Exelixis, Genentech, Infinity Pharmaceuticals, Merck & Co., Rigel Pharmaceuticals, TG Therapeutics, Sanofi Oncology, Vertex Pharmaceuticals, WILEX AG

What are the Application segmentation covered in the JAK and PI3K Signaling Pathway Market report?

Ans: The Applications covered in the JAK and PI3K Signaling Pathway Market report are Cancer, Inflammatory Diseases, Cardiac Ailments, Others

What are the Type segmentation covered in the JAK and PI3K Signaling Pathway Market report?

Ans: The Types covered in the JAK and PI3K Signaling Pathway Market report are PI3K, Janus Kinase Therapies (Inhibitors), PI3K Therapies (Inhibitors), Signal Transduction Biomarkers for JAK and PI3K

Recommended Reports

Cancer Therapies

Kinase Inhibitors

Inflammatory Disorders

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 PI3K
1.2.3 Janus Kinase Therapies (Inhibitors)
1.2.4 PI3K Therapies (Inhibitors)
1.2.5 Signal Transduction Biomarkers for JAK and PI3K
1.3 Market by Application
1.3.1 Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Inflammatory Diseases
1.3.4 Cardiac Ailments
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global JAK and PI3K Signaling Pathway Market Perspective (2019-2030)
2.2 Global JAK and PI3K Signaling Pathway Growth Trends by Region
2.2.1 JAK and PI3K Signaling Pathway Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 JAK and PI3K Signaling Pathway Historic Market Size by Region (2019-2024)
2.2.3 JAK and PI3K Signaling Pathway Forecasted Market Size by Region (2025-2030)
2.3 JAK and PI3K Signaling Pathway Market Dynamics
2.3.1 JAK and PI3K Signaling Pathway Industry Trends
2.3.2 JAK and PI3K Signaling Pathway Market Drivers
2.3.3 JAK and PI3K Signaling Pathway Market Challenges
2.3.4 JAK and PI3K Signaling Pathway Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue JAK and PI3K Signaling Pathway by Players
3.1.1 Global JAK and PI3K Signaling Pathway Revenue by Players (2019-2024)
3.1.2 Global JAK and PI3K Signaling Pathway Revenue Market Share by Players (2019-2024)
3.2 Global JAK and PI3K Signaling Pathway Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of JAK and PI3K Signaling Pathway, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global JAK and PI3K Signaling Pathway Market Concentration Ratio
3.4.1 Global JAK and PI3K Signaling Pathway Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by JAK and PI3K Signaling Pathway Revenue in 2023
3.5 Global Key Players of JAK and PI3K Signaling Pathway Head office and Area Served
3.6 Global Key Players of JAK and PI3K Signaling Pathway, Product and Application
3.7 Global Key Players of JAK and PI3K Signaling Pathway, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 JAK and PI3K Signaling Pathway Breakdown Data by Type
4.1 Global JAK and PI3K Signaling Pathway Historic Market Size by Type (2019-2024)
4.2 Global JAK and PI3K Signaling Pathway Forecasted Market Size by Type (2025-2030)
5 JAK and PI3K Signaling Pathway Breakdown Data by Application
5.1 Global JAK and PI3K Signaling Pathway Historic Market Size by Application (2019-2024)
5.2 Global JAK and PI3K Signaling Pathway Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America JAK and PI3K Signaling Pathway Market Size (2019-2030)
6.2 North America JAK and PI3K Signaling Pathway Market Size by Type
6.2.1 North America JAK and PI3K Signaling Pathway Market Size by Type (2019-2024)
6.2.2 North America JAK and PI3K Signaling Pathway Market Size by Type (2025-2030)
6.2.3 North America JAK and PI3K Signaling Pathway Market Share by Type (2019-2030)
6.3 North America JAK and PI3K Signaling Pathway Market Size by Application
6.3.1 North America JAK and PI3K Signaling Pathway Market Size by Application (2019-2024)
6.3.2 North America JAK and PI3K Signaling Pathway Market Size by Application (2025-2030)
6.3.3 North America JAK and PI3K Signaling Pathway Market Share by Application (2019-2030)
6.4 North America JAK and PI3K Signaling Pathway Market Size by Country
6.4.1 North America JAK and PI3K Signaling Pathway Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America JAK and PI3K Signaling Pathway Market Size by Country (2019-2024)
6.4.3 North America JAK and PI3K Signaling Pathway Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe JAK and PI3K Signaling Pathway Market Size (2019-2030)
7.2 Europe JAK and PI3K Signaling Pathway Market Size by Type
7.2.1 Europe JAK and PI3K Signaling Pathway Market Size by Type (2019-2024)
7.2.2 Europe JAK and PI3K Signaling Pathway Market Size by Type (2025-2030)
7.2.3 Europe JAK and PI3K Signaling Pathway Market Share by Type (2019-2030)
7.3 Europe JAK and PI3K Signaling Pathway Market Size by Application
7.3.1 Europe JAK and PI3K Signaling Pathway Market Size by Application (2019-2024)
7.3.2 Europe JAK and PI3K Signaling Pathway Market Size by Application (2025-2030)
7.3.3 Europe JAK and PI3K Signaling Pathway Market Share by Application (2019-2030)
7.4 Europe JAK and PI3K Signaling Pathway Market Size by Country
7.4.1 Europe JAK and PI3K Signaling Pathway Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe JAK and PI3K Signaling Pathway Market Size by Country (2019-2024)
7.4.3 Europe JAK and PI3K Signaling Pathway Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China JAK and PI3K Signaling Pathway Market Size (2019-2030)
8.2 China JAK and PI3K Signaling Pathway Market Size by Type
8.2.1 China JAK and PI3K Signaling Pathway Market Size by Type (2019-2024)
8.2.2 China JAK and PI3K Signaling Pathway Market Size by Type (2025-2030)
8.2.3 China JAK and PI3K Signaling Pathway Market Share by Type (2019-2030)
8.3 China JAK and PI3K Signaling Pathway Market Size by Application
8.3.1 China JAK and PI3K Signaling Pathway Market Size by Application (2019-2024)
8.3.2 China JAK and PI3K Signaling Pathway Market Size by Application (2025-2030)
8.3.3 China JAK and PI3K Signaling Pathway Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia JAK and PI3K Signaling Pathway Market Size (2019-2030)
9.2 Asia JAK and PI3K Signaling Pathway Market Size by Type
9.2.1 Asia JAK and PI3K Signaling Pathway Market Size by Type (2019-2024)
9.2.2 Asia JAK and PI3K Signaling Pathway Market Size by Type (2025-2030)
9.2.3 Asia JAK and PI3K Signaling Pathway Market Share by Type (2019-2030)
9.3 Asia JAK and PI3K Signaling Pathway Market Size by Application
9.3.1 Asia JAK and PI3K Signaling Pathway Market Size by Application (2019-2024)
9.3.2 Asia JAK and PI3K Signaling Pathway Market Size by Application (2025-2030)
9.3.3 Asia JAK and PI3K Signaling Pathway Market Share by Application (2019-2030)
9.4 Asia JAK and PI3K Signaling Pathway Market Size by Region
9.4.1 Asia JAK and PI3K Signaling Pathway Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia JAK and PI3K Signaling Pathway Market Size by Region (2019-2024)
9.4.3 Asia JAK and PI3K Signaling Pathway Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Type
10.2.1 Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Application
10.3.1 Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Country
10.4.1 Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer HealthCare Pharmaceuticals
11.1.1 Bayer HealthCare Pharmaceuticals Company Details
11.1.2 Bayer HealthCare Pharmaceuticals Business Overview
11.1.3 Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
11.1.4 Bayer HealthCare Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.1.5 Bayer HealthCare Pharmaceuticals Recent Developments
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie JAK and PI3K Signaling Pathway Introduction
11.2.4 AbbVie Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.2.5 AbbVie Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca JAK and PI3K Signaling Pathway Introduction
11.3.4 AstraZeneca Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.3.5 AstraZeneca Recent Developments
11.4 Curis
11.4.1 Curis Company Details
11.4.2 Curis Business Overview
11.4.3 Curis JAK and PI3K Signaling Pathway Introduction
11.4.4 Curis Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.4.5 Curis Recent Developments
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Details
11.5.2 Daiichi Sankyo Business Overview
11.5.3 Daiichi Sankyo JAK and PI3K Signaling Pathway Introduction
11.5.4 Daiichi Sankyo Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.5.5 Daiichi Sankyo Recent Developments
11.6 Exelixis
11.6.1 Exelixis Company Details
11.6.2 Exelixis Business Overview
11.6.3 Exelixis JAK and PI3K Signaling Pathway Introduction
11.6.4 Exelixis Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.6.5 Exelixis Recent Developments
11.7 Genentech
11.7.1 Genentech Company Details
11.7.2 Genentech Business Overview
11.7.3 Genentech JAK and PI3K Signaling Pathway Introduction
11.7.4 Genentech Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.7.5 Genentech Recent Developments
11.8 Infinity Pharmaceuticals
11.8.1 Infinity Pharmaceuticals Company Details
11.8.2 Infinity Pharmaceuticals Business Overview
11.8.3 Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
11.8.4 Infinity Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.8.5 Infinity Pharmaceuticals Recent Developments
11.9 Merck & Co.
11.9.1 Merck & Co. Company Details
11.9.2 Merck & Co. Business Overview
11.9.3 Merck & Co. JAK and PI3K Signaling Pathway Introduction
11.9.4 Merck & Co. Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.9.5 Merck & Co. Recent Developments
11.10 Rigel Pharmaceuticals
11.10.1 Rigel Pharmaceuticals Company Details
11.10.2 Rigel Pharmaceuticals Business Overview
11.10.3 Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
11.10.4 Rigel Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.10.5 Rigel Pharmaceuticals Recent Developments
11.11 TG Therapeutics
11.11.1 TG Therapeutics Company Details
11.11.2 TG Therapeutics Business Overview
11.11.3 TG Therapeutics JAK and PI3K Signaling Pathway Introduction
11.11.4 TG Therapeutics Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.11.5 TG Therapeutics Recent Developments
11.12 Sanofi Oncology
11.12.1 Sanofi Oncology Company Details
11.12.2 Sanofi Oncology Business Overview
11.12.3 Sanofi Oncology JAK and PI3K Signaling Pathway Introduction
11.12.4 Sanofi Oncology Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.12.5 Sanofi Oncology Recent Developments
11.13 Vertex Pharmaceuticals
11.13.1 Vertex Pharmaceuticals Company Details
11.13.2 Vertex Pharmaceuticals Business Overview
11.13.3 Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
11.13.4 Vertex Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.13.5 Vertex Pharmaceuticals Recent Developments
11.14 WILEX AG
11.14.1 WILEX AG Company Details
11.14.2 WILEX AG Business Overview
11.14.3 WILEX AG JAK and PI3K Signaling Pathway Introduction
11.14.4 WILEX AG Revenue in JAK and PI3K Signaling Pathway Business (2019-2024)
11.14.5 WILEX AG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Bayer HealthCare Pharmaceuticals
AbbVie
Astrazeneca plc
Curis
Daiichi Sankyo
Exelixis Inc
Genentech Inc
Infinity Pharmaceuticals
Merck
Rigel Pharmaceuticals
TG Therapeutics
Sanofi Oncology
Vertex Pharmaceuticals
Wilex
List of Tables
    Table 1. Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of PI3K
    Table 3. Key Players of Janus Kinase Therapies (Inhibitors)
    Table 4. Key Players of PI3K Therapies (Inhibitors)
    Table 5. Key Players of Signal Transduction Biomarkers for JAK and PI3K
    Table 6. Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global JAK and PI3K Signaling Pathway Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global JAK and PI3K Signaling Pathway Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global JAK and PI3K Signaling Pathway Market Share by Region (2019-2024)
    Table 10. Global JAK and PI3K Signaling Pathway Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global JAK and PI3K Signaling Pathway Market Share by Region (2025-2030)
    Table 12. JAK and PI3K Signaling Pathway Market Trends
    Table 13. JAK and PI3K Signaling Pathway Market Drivers
    Table 14. JAK and PI3K Signaling Pathway Market Challenges
    Table 15. JAK and PI3K Signaling Pathway Market Restraints
    Table 16. Global JAK and PI3K Signaling Pathway Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global JAK and PI3K Signaling Pathway Revenue Share by Players (2019-2024)
    Table 18. Global Top JAK and PI3K Signaling Pathway by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in JAK and PI3K Signaling Pathway as of 2023)
    Table 19. Global JAK and PI3K Signaling Pathway Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by JAK and PI3K Signaling Pathway Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of JAK and PI3K Signaling Pathway, Headquarters and Area Served
    Table 22. Global Key Players of JAK and PI3K Signaling Pathway, Product and Application
    Table 23. Global Key Players of JAK and PI3K Signaling Pathway, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global JAK and PI3K Signaling Pathway Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type (2019-2024)
    Table 27. Global JAK and PI3K Signaling Pathway Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type (2025-2030)
    Table 29. Global JAK and PI3K Signaling Pathway Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global JAK and PI3K Signaling Pathway Revenue Share by Application (2019-2024)
    Table 31. Global JAK and PI3K Signaling Pathway Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global JAK and PI3K Signaling Pathway Revenue Share by Application (2025-2030)
    Table 33. North America JAK and PI3K Signaling Pathway Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America JAK and PI3K Signaling Pathway Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America JAK and PI3K Signaling Pathway Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America JAK and PI3K Signaling Pathway Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America JAK and PI3K Signaling Pathway Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America JAK and PI3K Signaling Pathway Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America JAK and PI3K Signaling Pathway Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe JAK and PI3K Signaling Pathway Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe JAK and PI3K Signaling Pathway Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe JAK and PI3K Signaling Pathway Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe JAK and PI3K Signaling Pathway Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe JAK and PI3K Signaling Pathway Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe JAK and PI3K Signaling Pathway Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe JAK and PI3K Signaling Pathway Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China JAK and PI3K Signaling Pathway Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China JAK and PI3K Signaling Pathway Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China JAK and PI3K Signaling Pathway Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China JAK and PI3K Signaling Pathway Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia JAK and PI3K Signaling Pathway Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia JAK and PI3K Signaling Pathway Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia JAK and PI3K Signaling Pathway Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia JAK and PI3K Signaling Pathway Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia JAK and PI3K Signaling Pathway Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia JAK and PI3K Signaling Pathway Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia JAK and PI3K Signaling Pathway Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Bayer HealthCare Pharmaceuticals Company Details
    Table 66. Bayer HealthCare Pharmaceuticals Business Overview
    Table 67. Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Product
    Table 68. Bayer HealthCare Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 69. Bayer HealthCare Pharmaceuticals Recent Developments
    Table 70. AbbVie Company Details
    Table 71. AbbVie Business Overview
    Table 72. AbbVie JAK and PI3K Signaling Pathway Product
    Table 73. AbbVie Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 74. AbbVie Recent Developments
    Table 75. AstraZeneca Company Details
    Table 76. AstraZeneca Business Overview
    Table 77. AstraZeneca JAK and PI3K Signaling Pathway Product
    Table 78. AstraZeneca Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 79. AstraZeneca Recent Developments
    Table 80. Curis Company Details
    Table 81. Curis Business Overview
    Table 82. Curis JAK and PI3K Signaling Pathway Product
    Table 83. Curis Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 84. Curis Recent Developments
    Table 85. Daiichi Sankyo Company Details
    Table 86. Daiichi Sankyo Business Overview
    Table 87. Daiichi Sankyo JAK and PI3K Signaling Pathway Product
    Table 88. Daiichi Sankyo Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 89. Daiichi Sankyo Recent Developments
    Table 90. Exelixis Company Details
    Table 91. Exelixis Business Overview
    Table 92. Exelixis JAK and PI3K Signaling Pathway Product
    Table 93. Exelixis Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 94. Exelixis Recent Developments
    Table 95. Genentech Company Details
    Table 96. Genentech Business Overview
    Table 97. Genentech JAK and PI3K Signaling Pathway Product
    Table 98. Genentech Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 99. Genentech Recent Developments
    Table 100. Infinity Pharmaceuticals Company Details
    Table 101. Infinity Pharmaceuticals Business Overview
    Table 102. Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Product
    Table 103. Infinity Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 104. Infinity Pharmaceuticals Recent Developments
    Table 105. Merck & Co. Company Details
    Table 106. Merck & Co. Business Overview
    Table 107. Merck & Co. JAK and PI3K Signaling Pathway Product
    Table 108. Merck & Co. Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 109. Merck & Co. Recent Developments
    Table 110. Rigel Pharmaceuticals Company Details
    Table 111. Rigel Pharmaceuticals Business Overview
    Table 112. Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Product
    Table 113. Rigel Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 114. Rigel Pharmaceuticals Recent Developments
    Table 115. TG Therapeutics Company Details
    Table 116. TG Therapeutics Business Overview
    Table 117. TG Therapeutics JAK and PI3K Signaling Pathway Product
    Table 118. TG Therapeutics Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 119. TG Therapeutics Recent Developments
    Table 120. Sanofi Oncology Company Details
    Table 121. Sanofi Oncology Business Overview
    Table 122. Sanofi Oncology JAK and PI3K Signaling Pathway Product
    Table 123. Sanofi Oncology Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 124. Sanofi Oncology Recent Developments
    Table 125. Vertex Pharmaceuticals Company Details
    Table 126. Vertex Pharmaceuticals Business Overview
    Table 127. Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Product
    Table 128. Vertex Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 129. Vertex Pharmaceuticals Recent Developments
    Table 130. WILEX AG Company Details
    Table 131. WILEX AG Business Overview
    Table 132. WILEX AG JAK and PI3K Signaling Pathway Product
    Table 133. WILEX AG Revenue in JAK and PI3K Signaling Pathway Business (2019-2024) & (US$ Million)
    Table 134. WILEX AG Recent Developments
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global JAK and PI3K Signaling Pathway Market Share by Type: 2023 VS 2030
    Figure 3. PI3K Features
    Figure 4. Janus Kinase Therapies (Inhibitors) Features
    Figure 5. PI3K Therapies (Inhibitors) Features
    Figure 6. Signal Transduction Biomarkers for JAK and PI3K Features
    Figure 7. Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global JAK and PI3K Signaling Pathway Market Share by Application: 2023 VS 2030
    Figure 9. Cancer Case Studies
    Figure 10. Inflammatory Diseases Case Studies
    Figure 11. Cardiac Ailments Case Studies
    Figure 12. Others Case Studies
    Figure 13. JAK and PI3K Signaling Pathway Report Years Considered
    Figure 14. Global JAK and PI3K Signaling Pathway Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global JAK and PI3K Signaling Pathway Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global JAK and PI3K Signaling Pathway Market Share by Region: 2023 VS 2030
    Figure 17. Global JAK and PI3K Signaling Pathway Market Share by Players in 2023
    Figure 18. Global Top JAK and PI3K Signaling Pathway Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in JAK and PI3K Signaling Pathway as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by JAK and PI3K Signaling Pathway Revenue in 2023
    Figure 20. North America JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America JAK and PI3K Signaling Pathway Market Share by Type (2019-2030)
    Figure 22. North America JAK and PI3K Signaling Pathway Market Share by Application (2019-2030)
    Figure 23. North America JAK and PI3K Signaling Pathway Market Share by Country (2019-2030)
    Figure 24. United States JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe JAK and PI3K Signaling Pathway Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe JAK and PI3K Signaling Pathway Market Share by Type (2019-2030)
    Figure 28. Europe JAK and PI3K Signaling Pathway Market Share by Application (2019-2030)
    Figure 29. Europe JAK and PI3K Signaling Pathway Market Share by Country (2019-2030)
    Figure 30. Germany JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China JAK and PI3K Signaling Pathway Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China JAK and PI3K Signaling Pathway Market Share by Type (2019-2030)
    Figure 38. China JAK and PI3K Signaling Pathway Market Share by Application (2019-2030)
    Figure 39. Asia JAK and PI3K Signaling Pathway Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia JAK and PI3K Signaling Pathway Market Share by Type (2019-2030)
    Figure 41. Asia JAK and PI3K Signaling Pathway Market Share by Application (2019-2030)
    Figure 42. Asia JAK and PI3K Signaling Pathway Market Share by Region (2019-2030)
    Figure 43. Japan JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America JAK and PI3K Signaling Pathway Market Share by Country (2019-2030)
    Figure 53. Brazil JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries JAK and PI3K Signaling Pathway Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Bayer HealthCare Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 60. AbbVie Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 61. AstraZeneca Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 62. Curis Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 63. Daiichi Sankyo Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 64. Exelixis Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 65. Genentech Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 66. Infinity Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 67. Merck & Co. Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 68. Rigel Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 69. TG Therapeutics Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 70. Sanofi Oncology Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 71. Vertex Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 72. WILEX AG Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2019-2024)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Phosphoinositide 3 Kinase PI3K Inhibitors Market Insights Forecast to 2030
Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tyrosine Kinase JAK Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tyrosine Protein Kinase JAK1 Market Research Report 2024
Global Janus Kinase JAK Inhibitors Market Insights Forecast to 2030
Molecular Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Janus Kinase Inhibitors Market Research Report 2024
Global Kinase Inhibitors Market Insights Forecast to 2030
Molecular Targeted Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PI3K AKT mTor Pathway Inhibitors for Breast Cancer Market Research Report 2024
Global Nucleotide based Therapeutics Market Research Report 2024
Global BRAF Kinase Inhibitors Market Insights Forecast to 2030
Oligonucleotide Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PD 1 and PD L1 Immunotherapy Market Insights Forecast to 2030
Colorectal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti PD 1 Antibody Market Insights Forecast to 2030
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights Forecast to 2030
Global Jakinibs Market Insights Forecast to 2030
Global Metastatic Colorectal Cancer Drug Market Insights Forecast to 2030
Global TCR T Therapy Reagent Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions